Advanced search
1 file | 821.56 KB

Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies

(2017) CLINICAL CANCER RESEARCH. 23(21). p.6411-6420
Author
Organization
Keywords
CHRONIC LYMPHOCYTIC-LEUKEMIA, NON-HODGKIN-LYMPHOMA, REGULATORY T-CELLS, RESPONSE CRITERIA, MYCOSIS-FUNGOIDES, SEZARY-SYNDROME, CD27-CD70, INTERACTIONS, CANCER-IMMUNOTHERAPY, THERAPEUTIC TARGET, B-CELLS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 821.56 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Aftimos, Philippe, Christian Rolfo, Sylvie Rottey, Fritz Offner, Dominique Bron, Marie Maerevoet, Jean-Charles Soria, et al. 2017. “Phase I Dose-escalation Study of the anti-CD70 Antibody ARGX-110 in Advanced Malignancies.” Clinical Cancer Research 23 (21): 6411–6420.
APA
Aftimos, P., Rolfo, C., Rottey, S., Offner, F., Bron, D., Maerevoet, M., Soria, J.-C., et al. (2017). Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies. CLINICAL CANCER RESEARCH, 23(21), 6411–6420.
Vancouver
1.
Aftimos P, Rolfo C, Rottey S, Offner F, Bron D, Maerevoet M, et al. Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies. CLINICAL CANCER RESEARCH. 2017;23(21):6411–20.
MLA
Aftimos, Philippe, Christian Rolfo, Sylvie Rottey, et al. “Phase I Dose-escalation Study of the anti-CD70 Antibody ARGX-110 in Advanced Malignancies.” CLINICAL CANCER RESEARCH 23.21 (2017): 6411–6420. Print.
@article{8549655,
  author       = {Aftimos, Philippe and Rolfo, Christian and Rottey, Sylvie and Offner, Fritz and Bron, Dominique and Maerevoet, Marie and Soria, Jean-Charles and Moshir, Mahan and Dreier, Torsten and Van Rompaey, Luc and Michot, Jean-Marie and Silence, Karen and Hultberg, Anna and Gandini, Domenica and de Haard, Hans and Ribrag, Vincent and Peeters, Marc and Thibault, Alain and Leupin, Nicolas and Awada, Ahmad},
  issn         = {1078-0432},
  journal      = {CLINICAL CANCER RESEARCH},
  language     = {eng},
  number       = {21},
  pages        = {6411--6420},
  title        = {Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies},
  url          = {http://dx.doi.org/10.1158/1078-0432.CCR-17-0613},
  volume       = {23},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: